Home > Food & Beverages > Nutraceuticals > Fertility Supplements Market

Fertility Supplements Market Share

Report ID: GMI7083
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Fertility Supplements Market Share

Major companies operating in the fertility supplements industry include:

Fairhaven Health
Coast Science
Lenus Pharma GesmbH
Active Bio Life Science GmbH
Orthomol
Exeltis USA, Inc.
PregPrep LLC
MegaFood
Theralogix
Fertility Nutraceuticals LLC
Vitabiotics Ltd
Zenith Nutrition
GNC Holdings
Nutraceutical Corporation
Proxeed

Fairhaven Health is a producer of natural fertility products. Sperm supplements, prenatal vitamins, and fertility support supplements are among the goods available to both men and women at the firm. FertilAid for Women, OvaBoost, and CoQ10 for Women are just a few of the female fertility supplements available from Fairhaven Health. These vitamins promote hormone balance, egg health, and ovulation.

Authors: Kiran Pulidindi, Manish Mohanan

Frequently Asked Questions (FAQ) :

The market size of fertility supplement reached USD 1.9 billion in 2022 and is set to cross USD 4.4 billion by the end of 2032, says this GMI report.

Capsules segment held a dominant market share of over 40% in 2022, as they eliminate the need for measurement and mixing, making them a simple and hassle-free solution for people looking to improve their fertility.

North America market revenue was valued at USD 0.67 billion in 2022, as infertility is becoming more common in the region because of factors such as delayed childbirth, lifestyle changes, and environmental contaminants.

Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, MegaFood, Theralogix, Fertility Nutraceuticals LLC, Vitabiotics Ltd, Zenith Nutrition, GNC Holdings, Nutraceutical Corporation, and Proxeed.